FDA Inspection 1249053 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on July 3, 2024 in Santa Ana, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 3, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Santa Ana, CA (United States)